ClinVar Genomic variation as it relates to human health
NM_000067.3(CA2):c.232+1G>A
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000067.3(CA2):c.232+1G>A
Variation ID: 288909 Accession: VCV000288909.15
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 8q21.2 8: 85465470 (GRCh38) [ NCBI UCSC ] 8: 86377699 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Aug 22, 2016 Apr 6, 2024 Mar 14, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000067.3:c.232+1G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
splice donor NM_001293675.2:c.48+1G>A splice donor NC_000008.11:g.85465470G>A NC_000008.10:g.86377699G>A NG_007287.1:g.6454G>A - Protein change
- -
- Other names
-
IVS2DS, G-A, +1
- Canonical SPDI
- NC_000008.11:85465469:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00020 (A)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00000
Exome Aggregation Consortium (ExAC) 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00001
1000 Genomes Project 30x 0.00016
1000 Genomes Project 0.00020
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CA2 | - | - |
GRCh38 GRCh37 |
150 | 205 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Mar 14, 2024 | RCV000373455.11 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 10, 2022 | RCV000726247.8 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jul 15, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000343155.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 2
Sex: mixed
|
|
Pathogenic
(Jan 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Osteopetrosis with renal tubular acidosis
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002058668.1
First in ClinVar: Jan 15, 2022 Last updated: Jan 15, 2022 |
Comment:
Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are … (more)
Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region (PVS1_VS).The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000288909). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000004, PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Aggressive behavior (present) , Attention deficit hyperactivity disorder (present) , Cerebral calcification (present) , Global developmental delay (present) , Metabolic acidosis (present) , Osteopetrosis (present) … (more)
Aggressive behavior (present) , Attention deficit hyperactivity disorder (present) , Cerebral calcification (present) , Global developmental delay (present) , Metabolic acidosis (present) , Osteopetrosis (present) , Severe failure to thrive (present) (less)
|
|
Pathogenic
(Jan 10, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001769535.3
First in ClinVar: Aug 07, 2021 Last updated: Mar 04, 2023 |
Comment:
Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is … (more)
Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown.; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 16382316, 31130284, 25525159, 1301935, 25099932, 25674028, 28509178, 27717089, 15300855, 7959703, 29302074, 29620724, 30510438, 30109220, 32552793) (less)
|
|
Pathogenic
(Mar 14, 2024)
|
criteria provided, single submitter
Method: research
|
Osteopetrosis with renal tubular acidosis
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004801217.2
First in ClinVar: Mar 16, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(Jun 08, 2015)
|
no assertion criteria provided
Method: clinical testing
|
Osteopetrosis with renal tubular acidosis
(Autosomal recessive inheritance)
Affected status: yes, unknown
Allele origin:
germline
|
Baylor Genetics
Accession: SCV000328860.1
First in ClinVar: Dec 06, 2016 Last updated: Dec 06, 2016 |
Comment:
Our laboratory reported three molecular diagnoses in CA2 (NM_000067.2, c.232+1G>A), MCCC2 (NM_022132.4, c.1015G>A), and SPG11 (NM_025137.3, c.6100C>T) in one individual with clinical features of global … (more)
Our laboratory reported three molecular diagnoses in CA2 (NM_000067.2, c.232+1G>A), MCCC2 (NM_022132.4, c.1015G>A), and SPG11 (NM_025137.3, c.6100C>T) in one individual with clinical features of global developmental delay, developmental regression, autistic features, intellectual disability, hypotonia, ataxia, dysmorphic features, short stature, microcephaly, hyperextensibility, failure to thrive, structural brain abnormalities, skeletal abnormalities, and limb malformation. The CA2 variant has been previously reported as disease-causing [PMID 1301935]. Heterozygotes would be expected to be asymptomatic carriers. (less)
Observation 1:
Number of individuals with the variant: 1
Family history: yes
Age: 20-29 years
Sex: female
Geographic origin: Middle East
Observation 2:
Number of individuals with the variant: 1
Age: 10-19 years
Sex: male
Geographic origin: Qatar
|
|
Pathogenic
(Sep 18, 2017)
|
no assertion criteria provided
Method: clinical testing
|
Osteopetrosis with renal tubular acidosis
Affected status: yes
Allele origin:
germline
|
Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare
Accession: SCV000746078.1
First in ClinVar: Dec 06, 2016 Last updated: Dec 06, 2016 |
|
|
Pathogenic
(Aug 25, 2019)
|
no assertion criteria provided
Method: clinical testing
|
Osteopetrosis with renal tubular acidosis
Affected status: yes
Allele origin:
germline
|
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Accession: SCV001132952.1
First in ClinVar: Jan 04, 2020 Last updated: Jan 04, 2020 |
|
|
Pathogenic
(Jan 01, 1992)
|
no assertion criteria provided
Method: literature only
|
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000021116.3
First in ClinVar: Apr 04, 2013 Last updated: Apr 13, 2021 |
Comment on evidence:
Hu et al. (1992) pointed out that of the 39 reported cases of carbonic anhydrase deficiency syndrome (259730), 72% were patients from North Africa and … (more)
Hu et al. (1992) pointed out that of the 39 reported cases of carbonic anhydrase deficiency syndrome (259730), 72% were patients from North Africa and the Middle East countries, most, if not all, of whom were of Arab descent. They showed that members of 6 unrelated Arab kindreds were in 5 instances homozygous and in 1 instance heterozygous for a novel splice junction at the 5-prime end of intron 2. Called the 'Arabic mutation,' it introduces a new Sau3A1 restriction site useful in PCR-based diagnosis, carrier detection, and prenatal diagnosis. The presence of mental retardation and relative infrequency of skeletal fractures distinguish the clinical course of patients with the Arabic mutation from that of American and Belgian patients with the H107Y mutation (611492.0004). (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A splice junction mutation in intron 2 of the carbonic anhydrase II gene of osteopetrosis patients from Arabic countries. | Hu PY | Human mutation | 1992 | PMID: 1301935 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CA2 | - | - | - | - |
Text-mined citations for rs573750741 ...
HelpRecord last updated Aug 04, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.